Results 231 to 240 of about 22,711 (279)

An LNP antiviral siRNA drug cocktail delivered intranasally is effective against a range of respiratory viruses. [PDF]

Virol J
Oti VB, Ahmed T, Gao W, Acharya D, Wales-Earl L, Hicks A, McMillan NA, Idris A.   +7 more
europepmc   +1 more source

From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
Jessie Kim, Liam Lochhead, Cory R. Weissman   +2 more
wiley   +1 more source

Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery. [PDF]

Drug Des Devel Ther
Al Khzem AH, Gomaa MS.
europepmc   +1 more source

Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation. [PDF]

Vaccines (Basel)
Yao S, Zhai Z, Liao L, Zhong L, Shi C, Cheng YX, Liu X.   +6 more
europepmc   +1 more source

Is "Just-in-Case" catheterisation inappropriate or system-driven? A human factors perspective. [PDF]

Lancet Reg Health Eur
Galant J, Cazes N, Renard A.
europepmc   +1 more source

Ex Vivo Characterization and In Vivo Nasal Delivery of Ropinirole-Loaded PEO-b-PCL/Tween 80/β-Cyclodextrin Systems in C57BL/6J Mice. [PDF]

Molecules
Saitani EM, Papakyriakopoulou P, Balafas E, Damalas DE, Kostomitsopoulos N, Pispas S, Pippa N, Thomaidis N, Valsami G.   +8 more
europepmc   +1 more source

Lipid Nanoparticles for Nasal/Intranasal Drug Delivery

Critical Reviews in Therapeutic Drug Carrier Systems, 2017
Studies on the development of drug delivery systems have increased because these systems have particular characteristics that allow them to improve therapeutics. Among these, lipid nanoparticles (solid lipid nanoparticles, SLNs; and nanostructured lipid carriers, NLCs) have demonstrated suitability for drug targeting.
Sara C Cunha, Maria Helena Amaral, JOSÉ Manuel Sousa Lobo   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Mechanism of intranasal drug delivery directly to the brain

Life Sciences, 2018
Neurological diseases are becoming increasingly prominent worldwide due to rapidly aging populations, which greatly contributes to increasing healthcare costs. The development of neuroprotective drugs has so far proven exceptionally difficult due to the blood-brain barrier.
Tyler P Crowe, M Heather West Greenlee, Anumantha G Kanthasamy   +2 more
exaly   +3 more sources

Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics

Pharmaceutical Nanotechnology, 2018
The convoluted pathophysiology of brain disorders along with penetration issue of drugs to brain represents major hurdle that requires some novel therapies. The blood-brain barrier (BBB) denotes a rigid barrier for delivery of therapeutics in vivo; to overcome this barrier, intranasal delivery is an excellent strategy to deliver the drug directly to ...
Hitesh Kumar, Gaurav Mishra, Avinash Gothwal   +2 more
exaly   +3 more sources